logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Tris Pharma Inc drugs

    FiltersReset Filters
    16 results
    • cyproheptadine hydrochloride - cyproheptadine hydrochloride syrup

      (Cyproheptadine Hydrochloride)
      Tris Pharma Inc
    • dexmethylphenidate hydrochloride

      (dexmethylphenidate hydrochloride)
      Tris Pharma Inc
      Usage: Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
    • febuxostat - febuxostat tablet

      (Febuxostat)
      Tris Pharma Inc
    • hydrocodone bitartrate and acetaminophen

      (Hydrocodone Bitartrate and Acetaminophen)
      Tris Pharma Inc
      Usage: Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for managing severe pain when alternative treatments are inadequate. They should be used cautiously due to risks of addiction, abuse, and misuse, and are not intended for prolonged use unless absolutely necessary.
    • hydrocodone bitartrate and acetaminophen

      (Hydrocodone Bitartrate and Acetaminophen)
      Tris Pharma Inc
      Usage: Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the management of severe pain that requires opioid analgesics when alternative treatments are inadequate or intolerable. Long-term use is discouraged due to risks of addiction, abuse, and misuse.
    • hydrocodone bitartrate and acetaminophen - hydrocodone bitartrate and acetaminophen solution

      (Hydrocodone Bitartrate And Acetaminophen)
      Tris Pharma Inc
    • hydrocodone bitartrate and acetaminophen - hydrocodone bitartrate and acetaminophen solution

      (Hydrocodone Bitartrate And Acetaminophen)
      Tris Pharma Inc
    • lacosamide

      (Lacosamide)
      Tris Pharma Inc
      Usage: Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients aged 4 years and older.
    • levetiracetam

      (Levetiracetam)
      Tris Pharma Inc
      Usage: Levetiracetam is indicated for treating partial-onset seizures in patients aged 1 month and older, as adjunctive therapy for myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy, and for primary generalized tonic-clonic seizures in patients 6 years and older with idiopathic generalized epilepsy.
    • paliperidone - paliperidone tablet, extended release

      (Paliperidone)
      Tris Pharma Inc